Abemaciclib,Trastuzumab,sacituzumab,Fulvestrant
eli lilly,gilead sciences,Astrazeneca,roche
['monarche', 'breast', 'monarcher']
welcome to a full day of #esmo22 coverage. highlights today: data from important #breastcancer trials monarcher and tropics will be presented in paris later today. dana-farber's sara tolaney, md, mph, is senior author on both studies. 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090